Kernex Microsystems (KERNEX) — Investment Thesis

Status: OWNED (90 shares, ~₹1.01L invested, ~10% of portfolio)

Quality Score: 17/25 (Grade B: Moderate Conviction)

Classification: Multi-Bagger Candidate (Quality B + Base case 30% PAT CAGR, order book 12.6x revenue)

Last Updated: 2026-04-09 | CMP: ₹1,109 | Entry: ₹1,125 avg | P&L: -1.4% | Hold 90 shares (small speculative)

Data Source: Screener.in (consolidated), March 2025 investor presentation

> Recommendation: HOLD / ADD below ₹750. Kernex is one of only 3 RDSO-approved Kavach v4.0

> OEMs with a ₹3,268 Cr order book (12.6x revenue) anchored by India's mandated train collision

> avoidance rollout across 85,000 km. At ₹962 (normalised P/E ~54x), the market prices in ~28%

> growth versus our 30% estimate — thin margin of safety, but order book arithmetic and ₹14,600 Cr

> tender pipeline provide upside. Key condition: Q4 FY26 revenue must confirm ₹260+ Cr full-year

> trajectory and normalised tax rate must validate sustainable PAT.

Summary Verdict

Overall Multi-Bagger Probability: Medium-High — Extraordinary order book (12.6x revenue) with government-mandated demand. But company has never been profitable at scale; FY25 was the first real year. Execution risk is genuine, not theoretical.

Why this business?

India's railway network is deadly — and Kavach (Train Collision Avoidance System) is the government's mandated fix. Of 85,000 km of track, only ~1,500 km (1.8%) has been equipped. Kernex invented the underlying ACD/TCAS technology over 30 years ago and is one of just three companies with RDSO-approved Kavach v4.0 production capability. The order book tells the story: ₹3,268 Cr of signed government contracts sitting on top of a company that did ₹190 Cr revenue in FY25 — a 12.6x book-to-bill ratio that makes sub-25% growth arithmetically impossible from executing contracts already in hand. The bet is on execution, not demand: Indian Railways has committed ₹1.3 lakh Cr to safety in FY27, upcoming tenders worth ₹14,600 Cr provide a decade of order book replenishment, and the total addressable deployment across the full network is ₹4.25-6.8 lakh Cr. What makes this risky is that Kernex has never operated at scale — FY25 was literally the first profitable year, the balance sheet is small (₹174 Cr equity), and working capital requirements at ₹500 Cr revenue will strain the company unless funded by debt or dilution. This is a bet on a company with the right IP, the right contracts, and the right market position — but no track record of delivering at the scale the order book demands.

Strengths

• Regulatory moat with decade-long runway. One of 3 RDSO-approved Kavach v4.0 OEMs. Approval took years; Quadrant Future Tek has been in trials for 2+ years and still lacks final certification. Only 1.8% of the 85,000 km network deployed — runway is 15-20+ years at any reasonable execution pace.
• Order book provides arithmetic revenue certainty. ₹3,268 Cr backlog at 12.6x FY25 revenue. At 30% revenue CAGR, cumulative 5-year revenue is ₹2,460 Cr — still only 75% of current backlog. Growth is pre-sold, not speculative.
• Kavach IP originator with deep domain expertise. Kernex invented ACD/TCAS, the technology that became Kavach. 30+ years of Indian Railways integration. Hardware RDSO-approved, software 99% complete, ISA April 2025 — production-ready while competitors are still in trials.
• Asset-light model enables capital-efficient scaling. Fixed assets only ₹34 Cr supporting ₹259 Cr TTM revenue (7.6x asset turnover). Production capacity of 450 Kavach units/month (5,400/year) means manufacturing is not the bottleneck — capital goes to working capital, not factories.
• Massive tender pipeline for order book replenishment. Beyond current backlog: bids submitted ₹3,023 Cr + future bids ₹889 Cr + upgradation ₹121 Cr = ₹4,033 Cr pending. Near-term loco tenders worth ₹14,600 Cr provide visibility through FY30+.

Concerns

• First-ever profitable year — execution at scale is entirely unproven. FY25 PAT of ₹50 Cr was the company's first profit after cumulative losses of ₹64 Cr (FY22-FY24), and even that was inflated by a deferred tax credit (effective tax rate -54%). Normalised PAT is closer to ₹24 Cr. The company has never managed a ₹500+ Cr revenue business.
• Working capital will strain the balance sheet as revenue scales. At ₹500 Cr revenue with 150-day working capital cycle (government payment norms), ₹205 Cr gets locked in receivables and WIP — exceeding the entire equity base of ₹174 Cr. D/E already rose from 0.25 (FY25) to 0.51 (Sep 2025). Debt or dilution is likely.
• Near-monopoly customer dependency on Indian Railways. ~90%+ of revenue from a single sovereign buyer. Any pause in Kavach deployment — budget reallocation, political shift, bureaucratic delays — directly kills the growth trajectory. Defence diversification exists on paper but has zero revenue contribution.
• Low promoter holding with declining trend. 28.89% (Dec 2025), down from 29.08% (Mar 2025). No pledge, but low skin in the game relative to peers (HBL at 59%). Limits management accountability and governance quality.

The Compounding Equation

Kernex's compounding engine is unusual — it runs on government-mandated demand rather than competitive market dynamics. The incremental ROIC from FY23 to FY25 was 40%, but that number is misleading because it measures the jump from loss-making to first-year profitability. The more honest question is whether ROIC sustains at 20%+ as the capital base scales from ₹198 Cr to ₹500+ Cr.

The math works like this: Kernex reinvests 100% of earnings (zero dividends) into working capital needed to execute the order book. At a sustainable 25% ROIC on incremental capital, that implies 25% earnings growth — the conservative floor. The order book of ₹3,268 Cr physically guarantees this pace: at 30% revenue CAGR from ₹259 Cr TTM, cumulative 5-year revenue of ₹2,460 Cr consumes only 75% of the current backlog without a single new order win. The compounding fuel is contractual, not aspirational.

The vulnerability is working capital. Government projects pay on 90-120 day cycles. At ₹500 Cr revenue, the working capital locked up (~₹205 Cr) exceeds current equity (₹174 Cr). If Kernex funds this gap with debt, interest costs eat into margins (TTM interest already ₹18 Cr, up from ₹7 Cr in FY25). If it dilutes equity, per-share compounding slows. The compounding thesis requires Kernex to solve the balance sheet scaling problem — either through improving cash conversion (FY25 working capital days dropped from 1,731 to 177, a genuine positive signal) or through managed leverage that stays below 1.0x D/E. This is the single most important variable to monitor.

What does the market think — and where do I disagree?

At ₹962 (normalised P/E ~54x on ₹30 Cr TTM PAT), a reverse DCF at 13% required return over 6 years with 18x terminal multiple implies ~28% PAT growth. This is close to our 30% base estimate — the margin of safety is only 2 percentage points, which is thin.

The market is pricing in roughly base-case execution of the order book. Where I see potential disagreement is in two areas: (1) the ₹14,600 Cr upcoming tender pipeline, which if Kernex wins even 20-25% of, would push the order book above ₹6,000 Cr and extend the growth runway beyond what current pricing reflects; and (2) the possibility that normalised margins settle at 18-20% rather than the 17% I model, as scale economies on the asset-light model improve operating leverage. The gap is narrow but the asymmetry favours patience — bear case DCF is ₹601 (-38%) while bull case is ₹1,595 (+66%).

The Bull Case

Kernex holds RDSO-approved Kavach v4.0 IP as one of only 3 approved OEMs for India's mandated train collision avoidance system — a regulatory moat that took years to build and cannot be replicated quickly. The ₹3,268 Cr order book (12.6x FY25 revenue) makes sub-30% revenue growth arithmetically implausible just from executing signed contracts, while upcoming tenders worth ₹14,600 Cr+ (11,429 loco units + retendered orders) provide order book replenishment for a decade. If Kernex executes to ₹500 Cr revenue by FY28 at 25% net margin, PAT reaches ₹125 Cr; at 25x P/E that is ₹3,125 Cr market cap = ₹1,863/share = 1.9x from CMP, with further upside from defence and Moving Block System JV.

The Bear Case

Kernex was loss-making for FY22-FY24 (cumulative net loss of ₹64 Cr) — FY25 is literally the first year of profitability, and the ₹50 Cr PAT included a large deferred tax credit (tax rate was -54%, not a sustainable rate). Working capital will surge as revenue scales: at ₹500 Cr revenue with 150-day working capital cycle (government payment norms), ₹205 Cr of capital gets locked up vs current equity of ₹174 Cr — forcing debt or dilution. In the bear case, execution stalls at ₹300 Cr revenue, normalised net margin is 15% (not 27%), PAT is ₹45 Cr; at 20x P/E = ₹900 Cr market cap = ₹536/share = 44% drawdown from CMP.

Key Monitorables

1. Quarterly revenue run-rate: Must trend toward ₹100+ Cr/quarter by Q4 FY26 to confirm execution ramp. Q3 FY26 was ₹72.6 Cr — improving but not there yet. Source: BSE quarterly results

2. Normalised net margin: FY25 net margin of 26% was inflated by deferred tax credit. Track pre-tax margin (17% FY25) and normalised tax rate. Expect 20-22% net margin going forward. Source: Screener.in P&L

3. Working capital days: Cash conversion cycle collapsed from 1,731 (FY24) to 177 (FY25) — big improvement but still needs monitoring as revenue scales. OCF must turn consistently positive. Source: Screener.in ratios

4. Order book replenishment: Current ₹3,268 Cr. Must stay above ₹2,500 Cr even as execution ramps. New tender pipeline of ₹14,600 Cr is the replenishment source. Source: BSE filings, concalls

5. Borrowings trajectory: D/E was 0.25 in FY25, now ~0.51 (Sep 2025 borrowings ₹89 Cr on ₹174 Cr equity). If it crosses 1.0x, balance sheet strain is real. Source: Screener.in balance sheet

Data Gaps

1. Normalised tax rate: FY25 tax rate was -54% (deferred tax asset recognition). Need FY26 actual tax rate to compute true sustainable PAT. Check Q4 FY26 results.

2. Working capital funding plan: How will Kernex fund ₹200+ Cr of working capital at ₹500 Cr revenue? Debt, QIP, or internal accruals? Not disclosed.

3. Customer concentration by zonal railway: ~~PARTIALLY CLOSED~~ — CLW order spans 17 sheds in 7 zones: SER (8), SECR (3), CR (3), ECR (2), NCR (1), PLW (1), MELP (1). SER concentration (8/17 sheds) is notable. Still need revenue breakdown by zone.

4. Defence order pipeline details: Smart munitions and electronic fuzes mentioned but zero revenue/margin data disclosed. Actual pipeline value unknown. New products (NMS, Pulse Generators, Radio Modems, Drones) are adjacent-market extensions, not pure defence.

5. Kavach v4.0 competitive position: ~~PARTIALLY CLOSED~~ — Kernex TCAS 4.0 hardware RDSO-approved, software 99% complete, ISA April 2025. Quadrant Future Tek still in field trials. Kernex's production capacity (450 units/month) is quantified. Still need HBL/Medha capacity data for share comparison.

1. Business Summary

Kernex Microsystems is India's pioneer in railway safety signalling systems — Anti-Collision Devices (ACD), Train Collision Avoidance System (TCAS/Kavach), automatic block signalling (ABS), and telecom solutions for Indian Railways. The company is one of only three RDSO-approved Kavach v4.0 OEMs (alongside HBL Engineering and Medha Servo Drives), with the technology originally invented by Kernex as ACD. Revenue is almost entirely from Indian Railways (~90%+), with nascent diversification into defence (smart munitions, electronic fuzes) and a new 51:49 JV with Bharat Heavy Engineering for Moving Block System development. Beyond Kavach, the company has an emerging product pipeline: Network Management System (NMS, prototype June 2025), Pulse Generators (production Dec 2025), Radio Modems (production Aug 2025), and Drone Automation for railway inspection (project start April 2025) — all adjacent to core railway safety domain but not yet revenue-contributing. Level Crossing Gate production runs at 10/month, scalable to 25. The thesis is Kavach's mandated rollout across 44,000 km of Indian Railways creating a decade-long, contractually-committed revenue runway for a company that holds the foundational IP.

2. Quality Score + Kill Filter

Kill Filter

Kill Filter Verdict: PASS with multiple flags. The flags are serious but contextually defensible: (a) the company was in pre-revenue build phase FY22-FY24 with negative OCF expected for a project-based business ramping up, (b) FY25 was the inflection year — OCF turned positive, (c) single-customer risk is mitigated by the fact that Indian Railways is a sovereign entity with mandated Kavach spending, not a discretionary buyer. Low promoter holding (28.89%) remains a structural governance concern.

Quality Score

3. Compounding Engine — Q&A

Q1. Is incremental ROIC genuinely high (>20%) — and is it structural, not cyclical?

ROIC calculation:

`

NOPAT FY25 = EBIT × (1 - tax rate) = ₹32 Cr PBT + ₹7 Cr interest = ₹39 Cr EBIT

At normalised 25% tax: NOPAT = ₹39 × 0.75 = ₹29 Cr

Invested Capital FY25 = Total Equity ₹158 + Borrowings ₹40 - Cash (minimal) = ~₹198 Cr

ROIC (FY25) = 29 / 198 = 14.6% (on total capital)

`

Incremental ROIC (FY23→FY25):

`

Change in NOPAT: FY23 EBIT = -₹17 Cr → FY25 EBIT = ₹39 Cr → Δ = ₹56 Cr (pre-tax)

After normalised tax: Δ NOPAT = ₹56 × 0.75 = ₹42 Cr

Change in Capital Employed: FY23 CE (₹82 + ₹11) = ₹93 Cr → FY25 CE = ₹198 Cr → Δ = ₹105 Cr

Incremental ROIC = 42 / 105 = 40%

`

Incremental ROIC of 40% is excellent — but on a very small base, from negative to positive. The real test is whether ROIC sustains as capital employed scales to ₹500+ Cr.

Why it's structural (not cyclical): KERNEX holds RDSO-approved Kavach v4.0 IP — India's mandated train collision avoidance standard. This is a government-mandated safety regulation, not a demand cycle. The approval process took years and only 3 vendors have it (Kernex, HBL, Medha). The structural protection comes from: (a) RDSO certification barrier — Quadrant Future Tek has been in trials for 2+ years and still doesn't have final approval, (b) integration depth with Indian Railways systems built over 30+ years, (c) Kavach IP that KERNEX developed — marginal cost is manufacturing + installation, not R&D.

Honest check: If ROIC drops below 12% (cost of equity), the compounding thesis breaks. This would happen if: (a) Kavach pricing gets compressed by competitive bidding as 4th and 5th OEMs get approved, (b) working capital needs overwhelm the P&L at scale (90-120 day government payment cycles consuming all operating profit in receivables financing), or (c) normalised net margins are 10-12% (not the 26% shown in FY25 which was tax-credit-inflated).

Q2. How much capital can be redeployed at these returns — what's the reinvestment runway?

Reinvestment rate: ~100% of earnings retained. No dividends paid. Every rupee of profit is being redeployed into working capital and capacity for Kavach execution.

• Retained earnings FY25: ₹50 Cr (entire PAT)
• Capex FY25: ₹9 Cr (investing outflow) — asset-light model, most capital goes to working capital
• Working capital increase FY25: ₹35 Cr (Other Assets grew from ₹135 to ₹208 Cr)

Capital deployment opportunity:

• Kavach total addressable network: 85,000 km of Indian Railways (full network, per March 2025 investor presentation; earlier 44,000 km figure was initial HDN/HUN target). Only ~1,500 km deployed (1.8%).
• At ₹5-8 Cr per route-km for TCAS deployment, total Kavach TAM = ₹4.25-6.8 lakh Cr over 15-20 years.
• Near-term pipeline: HDN 11,000 km (7 routes) + HUN 24,230 km (11 routes) = 35,230 km addressable. Bids submitted ₹3,023 Cr + future ₹889 Cr = ₹3,912 Cr pending.
• Upcoming tender pipeline: 11,429 loco units worth ~₹9,000 Cr + retendered 10,000 units worth ~₹5,600 Cr = ₹14,600 Cr of near-term pipeline.
• Current order book ₹3,268 Cr at 12.6x FY25 revenue — massive visibility.
• Defence (smart munitions, electronic fuzes) and Moving Block System JV add separate reinvestment avenues at potentially higher margins.

Runway estimate: 15-20+ years — because: (a) Kavach deployment at current pace would take decades to cover the full 85,000 km network (expanded from initial 44,000 km HDN/HUN target); even at 5x acceleration it's a 15+ year programme, (b) technology upgrades and maintenance create recurring revenue on already-deployed segments, (c) Indian Railways FY27 safety budget exceeding ₹1.3 lakh Cr signals accelerating government commitment. The constraint is not demand saturation — it is execution bandwidth.

Q3. What's the implied compounding math?

Compounding formula:

• Reinvestment rate: ~100% (all earnings retained)
• ROIC on incremental capital: ~40% (FY23→FY25 incremental, but from a loss base — use 25-30% as sustainable estimate)
• Implied earnings growth: 100% × 25% = 25% CAGR (conservative floor)
• At 25% for 5 years: (1.25)^5 = 3.05x on earnings
• At 35% for 5 years: (1.35)^5 = 4.48x on earnings

Multi-bagger timeline (using normalised FY25 PAT of ₹35 Cr — adjusting for deferred tax):

• At 30% earnings CAGR for 5 years: ₹35 → ₹130 Cr PAT
• Entry P/E 30.7x. At mid-cap scale (₹3,000-5,000 Cr mcap), exit P/E de-rates to 25x.
• 5-year total return at 30% earnings growth + de-rating from 31x→25x: 3.71 × (25/31) = 3.0x
• 8-year total return at 30% earnings growth + de-rating from 31x→20x: 8.2 × (20/31) = 5.3x

Smell test: The 30% growth is achievable purely from executing the existing ₹3,268 Cr order book. At 30% revenue CAGR from ₹259 Cr (TTM): 5-year cumulative revenue = ₹2,460 Cr — still only 75% of the current backlog. The risk isn't the math — it's whether KERNEX can build the operational muscle to execute ₹500-1,000 Cr/year of projects when FY25 was its first ₹190 Cr year.

The order book sanity check: ₹3,268 Cr order book. At 40% revenue CAGR from ₹259 Cr base, cumulative 5Y revenue = ₹3,900 Cr — exceeds backlog, meaning new order wins are needed by Y4-5. At 30% CAGR, cumulative = ₹2,460 Cr — order book sustains growth through Y5 without any new wins.

Q4. What specifically kills the compounding?

The compounding breaks if: KERNEX fails to scale execution from ₹259 Cr (TTM) to ₹500+ Cr within 3 years — specifically, if working capital requirements at government payment cycles (90-120 days) cause a cash crunch that forces the company to slow project intake, take on expensive debt (D/E >1.5x), or dilute equity. At ₹500 Cr revenue with 150-day working capital cycle, working capital locked up = ~₹205 Cr. Current equity base is only ₹174 Cr. The scaling problem is a balance sheet constraint, not a demand constraint.

How I'd know it's breaking before the stock price tells me:

• Primary indicator: Quarterly revenue growth rate drops below 15% QoQ despite ₹3,000+ Cr order book. This means execution capacity — not demand — has hit a ceiling.
• Secondary indicator: Normalised pre-tax margin drops below 15% for 2 consecutive quarters. This signals either pricing pressure (competitive bidding) or overhead scaling faster than revenue.
• Third indicator: Borrowings cross ₹200 Cr (D/E >1.0x) without corresponding revenue ramp. This means the company is borrowing to fund working capital, not growth.
• Nuclear indicator: Kavach rollout officially paused or timeline extended by 5+ years. Probability: Low (political will is strong post-Balasore accident, FY27 budget confirms), but would remove demand urgency.

Q5. Can I hold this through a 40% drawdown? What's my conviction anchor?

My conviction anchor (the sentence I re-read at -40%):

> KERNEX has ₹3,268 Cr of signed government orders with RDSO-approved Kavach v4.0 IP as one of only 3 OEMs. The revenue is contractually committed regardless of stock price. Even at bear case execution, the order book alone guarantees 8+ years of growing revenue.

What I would NOT do in a drawdown: Sell. I would add below ₹700 (approaching bear DCF ₹536) if (a) order book is still >₹2,500 Cr, and (b) quarterly revenue is still growing. I would NOT add above ₹750 in a drawdown — let the price come to the bear floor before deploying more. Max position size: 12% of portfolio (currently ~10%).

Historical drawdown test: Stock fell from ~₹1,434 (52-week high) to ~₹672 (52-week low) — a 53% drawdown. The order book was unchanged. Revenue continued growing. The compounding engine survived because it was never the market sentiment that drove the thesis — it was the order book.

4. Key Metrics

Source: Screener.in (consolidated). Data as of Mar 2026.

P&L (Last 4 Years + TTM)

Important note on FY25 PAT: The ₹50 Cr net profit includes a large deferred tax credit (tax rate was -54%). Pre-tax profit was only ₹32 Cr. Normalised PAT at 25% tax = ~₹24 Cr. TTM normalised PAT at 25% tax on ₹40 Cr PBT = ~₹30 Cr. The headline P/E of 30.7x on ₹53 Cr TTM PAT understates true valuation; on normalised earnings P/E is closer to 54x.

Balance Sheet (Last 4 Years + Latest)

Balance sheet is inflecting rapidly. Total assets nearly doubled from FY25 (₹240 Cr) to Sep 2025 (₹461 Cr) — driven by Other Assets (₹208→₹427 Cr, likely receivables and WIP) and Other Liabilities (₹42→₹199 Cr, likely advances from Railways). Borrowings doubled to ₹89 Cr. This is the working capital expansion of a company scaling from ₹190 Cr to ₹300+ Cr revenue. Monitor closely.

Cash Flows

Cash conversion is the Achilles' heel. Three consecutive years of negative OCF (FY22-FY24). FY25 turned positive at ₹15 Cr but only 0.30x of PAT — well below the 0.7x comfort zone. Working capital absorbed most operating profit. This is the key financial risk: as revenue scales, OCF must keep pace or the company drowns in receivables.

Key Ratios

Working capital efficiency improved dramatically in FY25 — cash conversion cycle collapsed from 1,731 to 177 days. Debtor days dropped to 45. This is a genuine positive signal that the company is managing receivables better as it scales. If this holds, the OCF concern mitigates significantly.

Key Operating Metrics

Quarterly Trend (Last 6 Quarters)

Revenue trajectory: Q4 FY25 (₹83 Cr) was an outlier — likely year-end billing concentration typical of government contracts. Q1-Q3 FY26 total = ₹175.6 Cr vs Q1-Q3 FY25 = ₹106.7 Cr — 65% YoY growth on a 9-month basis. Annualised FY26 revenue pace: ₹235-280 Cr. Interest costs rising (₹18 Cr TTM vs ₹7 Cr FY25) as borrowings fund working capital.

4b. Outlook — Base Estimate + Sensitivity

Horizon: FY28 — 3-year forward (enough to see execution at scale)

Primary driver: ORDER BOOK

The ₹3,268 Cr order book at 12.6x TTM revenue provides arithmetic certainty of revenue growth — the only variable is execution pace. At FY26 9M pace of ₹175.6 Cr, full FY26 will likely be ₹250-280 Cr (includes Q4 March spike). The CLW order alone (₹2,465 Cr for 3,024 Kavach loco sets, 12-month timeline) provides visibility through FY27-FY28. Beyond current orders, the bid pipeline totals ₹4,033 Cr: bids submitted ₹3,023 Cr (9,505 km) + future bids ₹889 Cr (4,251 km) + upgradation ₹121 Cr (per March 2025 investor presentation). Near-term addressable network: HDN 11,000 km (7 routes) + HUN 24,230 km (11 routes) = 35,230 km — 23x what's been deployed (~1,500 km).

Base Fair Value (FY28 target):

• FY28 Revenue: ₹500 Cr (30% CAGR from ₹260 Cr FY26 base)
• Net margin: 17% (normalised) → PAT: ₹85 Cr
• At 25x P/E: Market cap ₹2,125 Cr → ₹1,265/share → +32% vs CMP ₹962

Key Sensitivities

Risk/reward: Downside 18% (execution stalls) / Upside 55-84% (margin holds + execution ramps) → Asymmetric upside

The one thing that makes the base case wrong: Working capital crunch forces Kernex to slow order execution, turning a 30% CAGR company into a 15% CAGR company that can never achieve the scale economics to justify current valuation.

5. Valuation

• Current Price: ₹962 | Market Cap: ₹1,616 Cr | Shares: 1.68 Cr
• Owner Earnings (PAT + D&A − maint. capex, TTM): ~₹53 + ₹5 − ₹5 = ₹53 Cr (but PAT is tax-credit inflated)
• Normalised TTM PAT (at 25% tax): ~₹30 Cr
• Headline P/E: 30.7x | Normalised P/E: ~54x

5.1 — Valuation Parameters

Method: Quality-adjusted DCF — Grade B (17/25)

5.2 — Margin of Safety Assessment

Reverse DCF — what growth rate is the market implying at CMP ₹962?

• Market Cap: ₹1,616 Cr | Normalised PAT: ₹30 Cr | Normalised P/E: ~54x
• At r=13%, n=6 years, Terminal Multiple=18x → Implied g = ~28%
• Is this reasonable? Yes — order book mathematically supports 30%+ CAGR. Market is pricing in roughly base-case execution.
• Gap between implied (28%) and estimated actual growth (30%) = 2pp margin of safety — thin.

What could go wrong:

If the biggest risk materializes (execution stall + margin compression): PAT stuck at ₹30-35 Cr, market de-rates to 15-18x → ₹450-630 Cr market cap → ₹268-375/share = 60-72% drawdown.

5.3 — Position Sizing

• Conviction level: Moderate (2 phases weak, 1 strong, 1 moderate)
• Recommended position size: 5-8% (2 phases weak → lean toward lower end)
• Current position: ~10% (slightly overweight for conviction level)
• Action: Hold; do not add above ₹800. Trim to 8% if P/E exceeds 60x on normalised earnings.

5.4 — Valuation Models

#### Model 1: Quality-Adjusted DCF (Order-Book Anchored)

Base normalised PAT: ₹30 Cr | FCF adjustment: 65% Y1-3, 75% Y4-6 | r: 13% | n: 6 years

Bear case (g=25%, terminal 15x):

`

Year-6 PAT = 30 × (1.25)^6 = 30 × 3.81 = ₹114 Cr

PV of interim FCF (65-75% of PAT, discounted):

Y1: 30×1.25×0.65/1.13 = ₹21.6 Y2: 30×1.56×0.65/1.28 = ₹23.8

Y3: 30×1.95×0.65/1.44 = ₹26.4 Y4: 30×2.44×0.75/1.63 = ₹33.7

Y5: 30×3.05×0.75/1.84 = ₹37.3 Y6: 30×3.81×0.75/2.08 = ₹41.3

Total interim PV = ₹184 Cr

Terminal Value = 114 × 15 = ₹1,715 Cr

PV of Terminal = 1,715 / 2.08 = ₹825 Cr

Total PV = 184 + 825 = ₹1,009 Cr

Per share = 1,009 / 1.68 = ₹601

`

Base case (g=30%, terminal 18x):

`

Year-6 PAT = 30 × (1.30)^6 = 30 × 4.83 = ₹145 Cr

PV of interim FCF:

Y1: 30×1.30×0.65/1.13 = ₹22.4 Y2: 30×1.69×0.65/1.28 = ₹25.7

Y3: 30×2.20×0.65/1.44 = ₹29.7 Y4: 30×2.86×0.75/1.63 = ₹39.4

Y5: 30×3.71×0.75/1.84 = ₹45.4 Y6: 30×4.83×0.75/2.08 = ₹52.2

Total interim PV = ₹215 Cr

Terminal Value = 145 × 18 = ₹2,606 Cr

PV of Terminal = 2,606 / 2.08 = ₹1,253 Cr

Total PV = 215 + 1,253 = ₹1,468 Cr

Per share = 1,468 / 1.68 = ₹874

`

Bull case (g=40%, terminal 22x):

`

Year-6 PAT = 30 × (1.40)^6 = 30 × 7.53 = ₹226 Cr

PV of interim FCF:

Y1: 30×1.40×0.65/1.13 = ₹24.2 Y2: 30×1.96×0.65/1.28 = ₹29.8

Y3: 30×2.74×0.65/1.44 = ₹37.0 Y4: 30×3.84×0.75/1.63 = ₹53.0

Y5: 30×5.38×0.75/1.84 = ₹65.7 Y6: 30×7.53×0.75/2.08 = ₹81.4

Total interim PV = ₹291 Cr

Terminal Value = 226 × 22 = ₹4,966 Cr

PV of Terminal = 4,966 / 2.08 = ₹2,388 Cr

Total PV = 291 + 2,388 = ₹2,679 Cr

Per share = 2,679 / 1.68 = ₹1,595

`

#### Model 2: P/B-ROE (Justified Price-to-Book)

Book Value: ₹103 | CoE: 13% | g = 6%

P/B-ROE is not meaningful for KERNEX — the model values steady-state ROE on current book value, but KERNEX is a pre-scale company where book value will 5-10x over the next 5 years as the order book converts to equity. P/B-ROE radically undervalues high-growth companies with low current book values. Ignore this model; DCF is the appropriate framework.

#### Synthesis

Verdict: Slightly Overvalued at CMP — Base DCF ₹874 implies 9% downside from ₹962. The stock is pricing in slightly above base-case execution. Not a screaming buy, but bull case (₹1,595, +66%) provides adequate upside IF execution accelerates.

Important caveat: The previous analysis used FY25 headline PAT of ₹50-51 Cr as the base, which was inflated by the deferred tax credit. Using normalised PAT of ₹30 Cr makes the valuation materially less attractive. The DCF base case is now ₹874 vs the old ₹1,689 — the old number was wrong because it used a non-normalised earnings base.

"What needs to be true for 5x in 5 years?" (₹4,810/share)

• Market cap ₹8,080 Cr. At 25x P/E: needs ₹323 Cr PAT.
• At 17% net margin on ₹1,900 Cr revenue.
• From TTM ₹259 Cr → needs 49% revenue CAGR for 5 years.
• Probability: Low-Medium — requires near-perfect execution + margin expansion + new order wins well beyond current backlog.
• More realistic path to 5x: 8 years at 30% PAT CAGR + stable 20-25x multiple.

6. Competitive Landscape

Market Position

Kernex is one of three RDSO-approved Kavach v4.0 OEMs, alongside HBL Engineering (listed) and Medha Servo Drives (unlisted). A fourth entrant, Quadrant Future Tek, is in final passenger field trials for Kavach v4.0 and expected to receive RDSO approval soon. Kernex is the smallest of the three approved OEMs by revenue but was the original inventor of the ACD/TCAS technology that became Kavach. Production capacity: 450 Kavach units/month + 10 Level Crossing Gates/month (scalable to 25). The addressable market is massive: 85,000 km of Indian Railways network (full network; initial HDN/HUN target was 44,000 km) at ₹5-8 Cr per route-km = ₹4.25-6.8 lakh Cr TAM, with only ~1.8% deployed. Near-term routes: HDN 11,000 km (7 routes) + HUN 24,230 km (11 routes) = 35,230 km.

Structural Advantages vs Peers

1. Kavach IP originator: Kernex invented ACD/TCAS → became Kavach. This gives deep domain expertise and RDSO relationship that competitors built later. Replication barrier: 30+ years of railway safety integration cannot be replicated. Quantified: Kernex holds ₹3,268 Cr of orders despite being 1/8th HBL's revenue — order book/revenue ratio is 12.6x vs HBL's ~2x.

2. RDSO v4.0 approval (early mover): Only 3 companies have full Kavach v4.0 approval. Quadrant Future Tek has been in trials for 2+ years and still pending. Quantified: approval barrier = 2-3 years minimum, limiting new entrants.

3. Asset-light model: Fixed assets only ₹34 Cr (Sep 2025) supporting ₹259 Cr TTM revenue = asset turnover 7.6x. Production capacity of 450 Kavach units/month (5,400/year) means manufacturing is NOT the bottleneck. Capital primarily goes to working capital (receivables), not fixed investment — allowing faster scaling if working capital is funded.

Peer Comparison

Why Multiples Differ + Re-rating Thesis

KERNEX at 30.7x vs HBL at 22.4x:

• KERNEX has higher OPM (22% vs 20%) and higher order book/revenue ratio (12.6x vs ~2x), justifying a growth premium
• But HBL has 11x the revenue, 59% promoter holding, near-zero debt, and a diversified business (batteries, defence electronics, railway signalling). HBL is a proven operator; KERNEX is a first-year profit company.
• HBL's lower P/E with 11x larger market cap reflects the de-risked nature of an established business

Re-rating thesis: If KERNEX demonstrates ₹400+ Cr revenue for 2 consecutive years with 20%+ OPM, the market will re-rate from "speculative small-cap" to "proven railway safety pure-play." At ₹400 Cr revenue, 17% net margin = ₹68 Cr PAT; at 30x P/E = ₹2,040 Cr market cap = ₹1,214/share = +26% from CMP. Combined with PAT growth, total return could be 50-80% over 2-3 years.

Competitive Dynamics

• Market share trend: Gaining — KERNEX went from ₹4 Cr revenue (FY23) to ₹190 Cr (FY25) while the Kavach deployment accelerated. Order book growing faster than execution.
• Primary competitive threat: HBL Engineering — 11x larger, better capitalised, 59% promoter holding, diversified revenue streams. HBL expects ₹1,300-1,500 Cr annual Kavach revenue by FY26-FY28. If Kavach becomes a 2-player market (HBL + Medha), Kernex's share shrinks.
• Key vulnerability: Smallest OEM by revenue — may lose large tenders to HBL/Medha on capacity/track record basis. Low promoter holding limits management's skin in the game.
• Policy tailwind: Indian Railways FY27 safety budget ₹1.3 lakh Cr — half of total railway capex. Kavach is politically mandated post-Balasore train accident. Strong tailwind.

7. Customer & Supplier Analysis

Customers

Concentration risk: EXTREME. Indian Railways is effectively the sole customer. This is partially mitigated by: (a) Railways is a sovereign entity — not going bankrupt, (b) Kavach is mandated by political will — not discretionary spending, (c) orders are multi-year contracts with CLW/zonal railways. But any pause in Kavach deployment directly kills revenue growth.

Suppliers

Supplier risk is low. No named supplier concentration disclosed. Primary risk is imported semiconductor components — global chip shortages could delay production. But Kernex's value-add is IP/integration, not hardware manufacturing.

7. Risks

8. Exit Triggers

• [ ] Order book declines below ₹2,000 Cr (execution eating into backlog without replenishment)
• [ ] Normalised net margin drops below 12% for 2 consecutive quarters
• [ ] Kavach rollout officially paused or delayed by 3+ years by government
• [ ] Promoter holding drops below 25%
• [ ] Quarterly revenue growth turns negative YoY despite ₹2,000+ Cr order book (execution failure)
• [ ] D/E exceeds 1.5x (balance sheet stress)
• [ ] Equity dilution >15% of current shares without corresponding order book growth

9. Review Schedule

• Next quarterly check: Q4 FY26 results (April/May 2026) — critical to see full-year FY26 revenue/PAT and ACTUAL tax rate
• Key events to watch:
• Q4 FY26 results: FY26 full-year revenue target ₹260+ Cr, normalised PAT ₹35+ Cr
• New Kavach tender awards from ₹14,600 Cr pipeline (11,429 + 10,000 loco units)
• Quadrant Future Tek RDSO approval — 4th OEM entry changes competitive dynamics
• Moving Block System JV (Bharat Heavy Engineering) progress
• Working capital and D/E trajectory in Sep 2025 / Mar 2026 balance sheets

11. Research Log

New learnings, commentary, and thesis updates — most recent first.

Full edit history: git log research/KERNEX.md

2026-03-28 — Investor Presentation Cross-Reference (March 2025 BSE Filing)

Source: BSE filing 172387c2-fb40-477b-8a62-bc8fa65eeb07.pdf — Kernex Investor Presentation, March 2025 (20 pages). Cross-referenced against existing thesis.

New Data Points (not previously in thesis):

1. Production Capacity Quantified: 450 Kavach units/month, 10 Level Crossing Gates/month (scalable to 25). This is the first concrete capacity ceiling we have. At 450 units/month × 12 = 5,400 units/year. CLW order alone is 3,024 loco sets — executable in ~7 months at full capacity. Capacity is NOT the bottleneck; execution coordination across 17 sheds in 7 railway zones is. (Merged into: Competitive Landscape, Business Summary)

2. TAM is 2x What We Modeled: Presentation states "entire 85,000 km Indian Railways network by 2030-2032" — our thesis used 44,000 km. The 44,000 km was likely the initial high-density route target; 85,000 km is the full network. At ₹5-8 Cr/route-km, full TAM = ₹4.25-6.8 lakh Cr (vs our ₹2.2-3.5 lakh Cr). Even if Kernex captures just 10% of the expanded TAM, that's ₹42,500-68,000 Cr of lifetime revenue opportunity. Growth Runway score of 5/5 further confirmed; runway is 15-20+ years, not 12-15. (Merged into: Q2 Reinvestment Runway, Competitive Landscape)

3. Bid Pipeline Visibility: Bids submitted ₹3,023 Cr (9,505 km) + Future bids ₹889 Cr (4,251 km) + Upgradation ₹121 Cr = ₹4,033 Cr of pending/upcoming bids. This is INCREMENTAL to the existing ₹3,268 Cr order book. If even 40% conversion, order book replenishment adds ₹1,600 Cr — removing our concern about order book depletion by Y4-5. (Merged into: Outlook, Q2)

4. HDN + HUN Route Specifics:

- HDN (High Density Network): 11,000 km across 7 routes

- HUN (Highly Utilised Network): 24,230 km across 11 routes

- Total near-term addressable: 35,230 km — 23x what's been deployed (~1,500 km)

- This answers our "Data Gap #5" about upcoming tender pipeline distribution

(Merged into: Outlook, Competitive Landscape)

5. New Product Diversification (Revenue Optionality):

- Network Management System (NMS): Prototype June 2025 — monitoring infrastructure

- Pulse Generators: Production December 2025 — component for signalling

- Radio Modems: Production August 2025 — communication equipment

- Drone Automation: Project start April 2025 — railway inspection drones

- These reduce single-product dependency. Each is adjacent to core railway safety domain. Not yet revenue-contributing but shows R&D pipeline beyond pure Kavach execution.

(Merged into: Business Summary, Data Gaps #4)

6. CLW Execution Granularity:

- 17 locomotive sheds across 7 zones: SER (8), SECR (3), CR (3), ECR (2), NCR (1), PLW (1), MELP (1)

- 2,302 total locomotives to be equipped

- Status (as of March 2025): Survey completed, testbenches laid out, simulators ready for inspection

- Materials supply: Started April 2025 | Delivery: From May 2025 | Installation: From June 2025

- 7-zone spread de-risks geographic concentration but adds coordination complexity.

(Merged into: Customer section)

7. TCAS 4.0 Development Status:

- Hardware: RDSO approved

- Software: 99% complete

- ISA (Independent Safety Assessment): April 2025

- Kernex's v4.0 is essentially production-ready, while Quadrant Future Tek is still in passenger field trials. Technology moat intact.

(Merged into: Data Gaps #5)

Thesis Confirmations:

• Order book trajectory: ₹2,124 Cr (Mar 2025) → ₹3,268 Cr (Dec 2025) = 54% growth in 9 months. Order book replenishment keeping pace — confirmed.
• EBITDA margins: 22-23% in 9M FY25, consistent with our 20-25% base case range.
• Asset-light model: No heavy capex disclosed. Production is integration + assembly, not manufacturing.
• CFO turnaround: 9M FY25 CFO +₹5.31 Cr vs 9M FY24 -₹67 Cr. Supports OCF improvement narrative.

Thesis Challenge:

• 85,000 km by 2030-2032 is extremely ambitious — only ~1,500 km deployed in 30+ years. Government timeline slippage probability is HIGH. Don't model off this timeline; use 15-20 year deployment as realistic assumption.
• March 2025 order book was ₹2,124 Cr (KMIL exclusive ₹1,735 Cr + consortium ₹389 Cr). The jump to ₹3,268 Cr by Dec 2025 means ₹1,144 Cr of new orders in 9 months — need to verify this pace sustains.

Valuation Impact:

• No change to base DCF (₹874) — the presentation is 12 months old, and our model already uses Dec 2025 data
• Bull case strengthened: TAM 2x larger (85,000 km vs 44,000 km), bid pipeline ₹4,033 Cr provides order book replenishment runway, new products add optionality
• Execution capacity confirmed: 450 units/month production capacity removes manufacturing bottleneck concern
• If order book hits ₹6,000+ Cr with confirmed CLW execution, bull DCF could move from ₹1,595 to ₹1,800+ — but wait for Q4 FY26 actuals

2026-03-25 — Order Book Update & Revised Valuation (Post Q3 FY26)

Order Book Update:

• Q3 FY26 order book: ₹3,268 Cr (12.6x FY25 revenue of ₹259 Cr)
• NEW: CLW contract — ₹2,465 Cr for 3,024 Kavach locomotive sets, 12-month execution deadline (flows through FY27)
• NEW: BLW contract — ₹411 Cr for 505 Kavach units
• Potential total order book post new wins: ~₹6,100 Cr (~24x FY25 revenue)

Revised Valuation Scenario (FY27):

• If ₹1,000+ Cr revenue executed in FY27 at 10% EBITDA margin → ~₹100 Cr PAT
• At 20x forward PE → implied market cap ₹2,000 Cr+ vs current ~₹800 Cr
• Upside case: 2.5x from current ₹915 if execution holds
• Previous ₹700 buy zone was set before CLW/BLW order wins — reassess threshold given order book step-change

Key Remaining Risks (unchanged):

• Promoter holding low (28.89%) and declining
• First profitable year (FY25) — execution capacity at scale unproven
• Balance sheet leverage (D/E 0.51x, will rise with working capital)
• 12-month CLW deadline is aggressive — any execution slippage = significant downside
• Bear case ₹536/share still valid if execution disappoints

Revised Action: Positions below ₹1,000 are justifiable given order book step-change. Watch Q4 FY26 as confirmation of execution velocity.

2026-03-22 — Full framework rewrite (new template)

Key corrections from old thesis:

• Quality Score downgraded 18→17: Management 3→2 (low promoter, no scaling record), Financials 4→3 (corrected OCF data, rising debt)
• FY25 PAT of ₹50 Cr is tax-credit inflated. Tax rate was -54% (deferred tax asset). Normalised PAT at 25% tax = ~₹24 Cr on ₹32 Cr PBT. This changes valuation dramatically.
• Old DCF base ₹1,689 was WRONG — used FY25 headline PAT ₹51 Cr as base. Normalised base ₹30 Cr gives DCF base ₹874. Stock is now slightly overvalued at ₹962, not 66% undervalued.
• OCF was negative for 3 consecutive years (FY22-FY24). Old thesis understated this. FY25 OCF positive but only 0.30x PAT.
• Borrowings rising faster than expected: ₹40 Cr (FY25) → ₹89 Cr (Sep 2025). D/E 0.51 and climbing.
• Competitive landscape added: HBL is 11x larger by revenue with 59% promoter holding. Medha is 23x larger. Kernex is the smallest OEM. Quadrant Future Tek nearing 4th OEM approval.
• Full financial history corrected: Company was loss-making FY22-FY24 (cumulative loss ₹64 Cr). Revenue was ₹7, ₹4, ₹20 Cr — not ₹35, ₹85, ₹190 as old thesis stated (those may have been standalone vs consolidated confusion).
• Compounding Engine Q&A retained — restructured with corrected numbers
• Buy zone lowered: Old ₹850-950 → New ₹600-750 based on corrected DCF

2026-03-21 — Section 3 overhaul: Compounding Engine Q&A

• Replaced catalyst list with 5-question first-principles framework
• Q1: Incremental ROIC ~40% (from loss base). Structural — RDSO-approved IP, government-mandated standard
• Q2: Reinvestment runway 12-15+ years (44,000 km Kavach, 3.4% deployed)
• Q3: Math — 100% reinvestment x 25-30% ROIC = 25-30% earnings CAGR
• Q4: Kill condition — fails to scale past ₹500 Cr revenue due to working capital crunch
• Q5: Conviction anchor — signed government orders, survived 53% drawdown with thesis intact

2026-04-09 — New orders + BHE JV + CMP update

CMP has risen to ₹1,109 from ₹962 at research date (+15%). Position near breakeven (avg ₹1,125). Hold 90 shares. Do not add above ₹750 — bear case -53% remains the constraint. Source: portfolio restructuring session Apr 9, 2026.

New KAVACH orders received (two separate awards):

• ₹91.12 Cr for 112 KAVACH equipment sets
• ₹411.17 Cr for 505 KAVACH onboard units
• Total: ₹502 Cr in fresh order inflows → order book grows from ₹3,268 Cr to ~₹3,770 Cr

This matters because order replenishment was the key monitorable. New wins confirm Indian Railways is executing Kavach deployment, not just budgeting for it. The ₹502 Cr inflow in a company with ₹259 Cr TTM revenue = 2x annual revenue added in one quarter of wins. Source: Screener.in announcements, Apr 2026.

BHE Joint Venture for Moving Block System — major strategic development.

Kernex has entered a JV with Bharat Heavy Engineering for a Moving Block System integrated with KAVACH. This is significant because:

• KAVACH v4.0 is the current mandate (fixed block signalling); Moving Block is the next-generation system (European Train Control System equivalent) that increases rail capacity by 30-40% without new tracks
• If Kernex is in the JV at the ground floor, it secures a position in the upgrade cycle that follows KAVACH deployment — not just the initial rollout but the subsequent modernization wave
• BHE brings manufacturing depth; Kernex brings RDSO-approved IP and Railways relationship
• Runway extension: from 44,000 km KAVACH mandate to potential 44,000 km Moving Block upgrade on top — doubles the addressable opportunity over a 15-20 year horizon
• No revenue contribution yet; this is optionality, not base case

Government policy tailwinds — why KAVACH deployment is accelerating:

After the Odisha train collision (June 2023) that killed 290 people, the Indian government made KAVACH deployment a political priority. Railway Budget 2025-26 allocated ₹1.3 lakh Cr to safety, with 5,000 km of additional KAVACH coverage announced. The Railway Ministry has shifted from "pilot and evaluate" mode to "mass deploy" mode — this is the difference between a speculative order book and a contractually committed pipeline. Kernex is one of 3 approved vendors absorbing a politically-driven deployment mandate. Risk: deployment pace can still slow on bureaucratic/budget grounds; a change in Railway Minister would introduce uncertainty.

Q3 FY26 actuals: Revenue ₹72 Cr, PAT ₹6 Cr. Q2 FY26: Revenue ₹45 Cr, PAT ₹2.5 Cr. The quarterly numbers look small against a ₹3,770 Cr order book — but this is the nature of project-based revenue: recognition is milestone-linked, not linear. The important metric is cumulative 9M FY26 revenue (₹171 Cr vs ₹190 Cr full-year FY25) — confirms the company is scaling, not stalling. Q4 FY26 confirmation above ₹260 Cr full-year remains the key trigger. Source: Screener.in, Apr 2026.

ROCE and returns: ROCE now 22.3%, ROE 34.4% — both improved from initial research. Confirms the business model scales well as revenue grows. P/E 38.3x on ₹49 Cr TTM PAT — expensive on trailing, but order book arithmetic makes trailing PE misleading. The correct frame is 18-24 month forward PE as order book converts to revenue.

2026-03-11 — Initial thesis created

• Built initial valuation models
• Key insight: massive order book provides revenue visibility
• Risk is execution at scale — company had never been profitable
• Low promoter holding (28.89%) noted as concern

Version History

🆕 Order Book Update & Revised Valuation (March 2026)

New Order Wins (Post Q3 FY26)

• Q3 FY26 order book: ₹3,268 Cr (12.6x FY25 revenue of ₹259 Cr)
• NEW — CLW contract: ₹2,465 Cr for 3,024 Kavach locomotive sets; 12-month execution deadline → flows through FY27
• NEW — BLW contract: ₹411 Cr for 505 Kavach units
• Potential total order book post wins: ~₹6,100 Cr (~24x FY25 revenue)

Revised FY27 Valuation Scenario

> Previous ₹700 buy zone was set before CLW/BLW order wins. With order book at ~₹6,100 Cr, threshold should be reassessed.

Key Remaining Risks (Unchanged)

• Promoter holding only 28.89% and declining — governance concern
• FY25 was first ever profitable year — execution capacity at scale unproven
• D/E rising (0.51x); working capital will balloon as revenue scales
• 12-month CLW deadline is aggressive — execution slippage = significant downside
• Bear case ₹536/share still valid if execution disappoints

Revised Action

Below ₹1,000 is justifiable given order book step-change. Q4 FY26 results are the key execution confirmation.